Entity Common Stock, Shares Outstanding of Syndax Pharmaceuticals Inc from 05 May 2016 to 23 Feb 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Syndax Pharmaceuticals Inc quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 05 May 2016 to 23 Feb 2026.
  • Syndax Pharmaceuticals Inc Entity Common Stock, Shares Outstanding for the quarter ending 23 Feb 2026 was 88,200,596, a 2.5% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Syndax Pharmaceuticals Inc Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 88,200,596 +2,153,147 +2.5% 23 Feb 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 86,914,838 31 Oct 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 86,141,862 +1,045,504 +1.2% 01 Aug 2025 10-Q 04 Aug 2025 2025 Q2
Q1 2025 86,047,449 +1,060,389 +1.2% 01 May 2025 10-Q 05 May 2025 2025 Q1
Q2 2024 85,096,358 +15,612,305 +22% 25 Jul 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 84,987,060 +16,165,783 +23% 01 May 2024 10-Q 08 May 2024 2024 Q1
Q3 2023 69,640,668 +9,417,170 +16% 27 Oct 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 69,484,053 +12,918,888 +23% 27 Jul 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 68,821,277 +13,809,032 +25% 03 May 2023 10-Q 08 May 2023 2023 Q1
Q3 2022 60,223,498 +10,831,375 +22% 02 Nov 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 56,565,165 +7,937,554 +16% 05 Aug 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 55,012,245 +6,776,486 +14% 25 Feb 2022 10-K 01 Mar 2022 2021 FY
Q3 2021 49,392,123 +8,522,901 +21% 11 Nov 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 48,627,611 +10,078,413 +26% 06 Aug 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 48,235,759 +17,994,921 +60% 10 Mar 2021 10-K/A 30 Apr 2021 2020 FY
Q3 2020 40,869,222 +13,728,738 +51% 04 Nov 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 38,549,198 +11,412,404 +42% 05 Aug 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 30,240,838 +5,240,098 +21% 04 Mar 2020 10-K 05 Mar 2020 2019 FY
Q3 2019 27,140,484 +2,304,533 +9.3% 06 Nov 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 27,136,794 +3,781,781 +16% 06 Aug 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 25,000,740 +302,796 +1.2% 06 Mar 2019 10-K 07 Mar 2019 2018 FY
Q3 2018 24,835,951 +446,022 +1.8% 02 Nov 2018 10-Q 05 Nov 2018 2018 Q3
Q2 2018 23,355,013 +1,135,035 +5.1% 06 Aug 2018 10-Q 08 Aug 2018 2018 Q2
Q1 2018 24,697,944 +6,453,521 +35% 05 Mar 2018 10-K 08 Mar 2018 2017 FY
Q3 2017 24,389,929 +6,196,569 +34% 06 Nov 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 22,219,978 +4,437,828 +25% 10 Aug 2017 10-Q 10 Aug 2017 2017 Q2
Q1 2017 18,244,423 +462,273 +2.6% 07 Mar 2017 10-K 14 Mar 2017 2016 FY
Q3 2016 18,193,360 07 Nov 2016 10-Q 14 Nov 2016 2016 Q3
Q2 2016 17,782,150 08 Aug 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 17,782,150 05 May 2016 10-Q 16 May 2016 2016 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.